Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000563808> ?p ?o ?g. }
- W2000563808 endingPage "2475" @default.
- W2000563808 startingPage "2464" @default.
- W2000563808 abstract "Abstract Pancreatic adenocarcinoma confers one of the highest mortality rates in malignant human tumors with very poor prognosis. Because as yet no treatments are available that produce a substantial survival benefit for this fatal neoplasia, new therapeutic concepts are urgently required to support cancer standard treatment. In search of tumor-associated gangliosides with therapeutic background, we probed a random collection of cancerous and adjacent normal postoperative tissue samples from 38 patients for the expression of CD75s- and iso-CD75s-gangliosides. We exhaustively analyzed the expression of CD75s-1-ganglioside (IV6Neu5Ac-nLc4Cer) and structurally closely related iso-CD75s-1-ganglioside (IV3Neu5Ac-nLc4Cer) by means of immunohistology of cryosections and semiquantitative TLC of tissue lipid extracts combined with mass spectrometry. CD75s-1- and iso-CD75s-1-ganglioside showed an elevated expression in 42% and 66% of the tumors, respectively, indicating a significant association with neoplastic transformation (P = 0.001). Thus, increased expression of CD75s-1- and iso-CD75s-1-gangliosides renders these cell surface molecules promising candidates for oncologic applications. Further statistical analysis revealed a significant enhancement of CD75s-1-ganglioside in the group of less differentiated tumors (grade >2) suggesting this ganglioside as a potential marker for poor differentiation. The CD75s-specific antitumor drug rViscumin, which represents the recombinant counterpart of the ribosome-inactivating lectin viscumin, has successfully passed clinical phase I trials and provides an opportunity for treating pancreatic cancer. Consequently, if an enhanced expression is existent in malignant tissues, we propose the targeting of CD75s-gangliosides with rViscumin as a novel potential strategy in adjuvant treatment of pancreatic malignancies. [Mol Cancer Ther 2008;7(8):2464–12]" @default.
- W2000563808 created "2016-06-24" @default.
- W2000563808 creator A5001957758 @default.
- W2000563808 creator A5008070317 @default.
- W2000563808 creator A5008757972 @default.
- W2000563808 creator A5014489598 @default.
- W2000563808 creator A5018195444 @default.
- W2000563808 creator A5027497245 @default.
- W2000563808 creator A5034946687 @default.
- W2000563808 creator A5045653209 @default.
- W2000563808 creator A5051645511 @default.
- W2000563808 creator A5055260011 @default.
- W2000563808 creator A5058710861 @default.
- W2000563808 creator A5064045497 @default.
- W2000563808 creator A5064531404 @default.
- W2000563808 creator A5083490249 @default.
- W2000563808 date "2008-08-01" @default.
- W2000563808 modified "2023-10-17" @default.
- W2000563808 title "Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer" @default.
- W2000563808 cites W1508805699 @default.
- W2000563808 cites W1511540332 @default.
- W2000563808 cites W1964080151 @default.
- W2000563808 cites W1965734230 @default.
- W2000563808 cites W1967907887 @default.
- W2000563808 cites W1976855246 @default.
- W2000563808 cites W1985774086 @default.
- W2000563808 cites W1997811602 @default.
- W2000563808 cites W2006808589 @default.
- W2000563808 cites W2008403169 @default.
- W2000563808 cites W2021586229 @default.
- W2000563808 cites W2022797612 @default.
- W2000563808 cites W2024896179 @default.
- W2000563808 cites W2025060953 @default.
- W2000563808 cites W2032500498 @default.
- W2000563808 cites W2037049457 @default.
- W2000563808 cites W2046637277 @default.
- W2000563808 cites W2056042508 @default.
- W2000563808 cites W2066835391 @default.
- W2000563808 cites W2075409749 @default.
- W2000563808 cites W2075525089 @default.
- W2000563808 cites W2081177279 @default.
- W2000563808 cites W2084306621 @default.
- W2000563808 cites W2091215785 @default.
- W2000563808 cites W2096005822 @default.
- W2000563808 cites W2101893195 @default.
- W2000563808 cites W2102847072 @default.
- W2000563808 cites W2106657658 @default.
- W2000563808 cites W2107958423 @default.
- W2000563808 cites W2120500844 @default.
- W2000563808 cites W2128490622 @default.
- W2000563808 cites W2134528192 @default.
- W2000563808 cites W2140024351 @default.
- W2000563808 cites W2148918528 @default.
- W2000563808 cites W2156402312 @default.
- W2000563808 doi "https://doi.org/10.1158/1535-7163.mct-08-0353" @default.
- W2000563808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18723492" @default.
- W2000563808 hasPublicationYear "2008" @default.
- W2000563808 type Work @default.
- W2000563808 sameAs 2000563808 @default.
- W2000563808 citedByCount "29" @default.
- W2000563808 countsByYear W20005638082012 @default.
- W2000563808 countsByYear W20005638082014 @default.
- W2000563808 countsByYear W20005638082017 @default.
- W2000563808 countsByYear W20005638082018 @default.
- W2000563808 countsByYear W20005638082019 @default.
- W2000563808 countsByYear W20005638082023 @default.
- W2000563808 crossrefType "journal-article" @default.
- W2000563808 hasAuthorship W2000563808A5001957758 @default.
- W2000563808 hasAuthorship W2000563808A5008070317 @default.
- W2000563808 hasAuthorship W2000563808A5008757972 @default.
- W2000563808 hasAuthorship W2000563808A5014489598 @default.
- W2000563808 hasAuthorship W2000563808A5018195444 @default.
- W2000563808 hasAuthorship W2000563808A5027497245 @default.
- W2000563808 hasAuthorship W2000563808A5034946687 @default.
- W2000563808 hasAuthorship W2000563808A5045653209 @default.
- W2000563808 hasAuthorship W2000563808A5051645511 @default.
- W2000563808 hasAuthorship W2000563808A5055260011 @default.
- W2000563808 hasAuthorship W2000563808A5058710861 @default.
- W2000563808 hasAuthorship W2000563808A5064045497 @default.
- W2000563808 hasAuthorship W2000563808A5064531404 @default.
- W2000563808 hasAuthorship W2000563808A5083490249 @default.
- W2000563808 hasBestOaLocation W20005638082 @default.
- W2000563808 hasConcept C121608353 @default.
- W2000563808 hasConcept C126322002 @default.
- W2000563808 hasConcept C2777331542 @default.
- W2000563808 hasConcept C2777982462 @default.
- W2000563808 hasConcept C2780210213 @default.
- W2000563808 hasConcept C2781182431 @default.
- W2000563808 hasConcept C502942594 @default.
- W2000563808 hasConcept C55493867 @default.
- W2000563808 hasConcept C71924100 @default.
- W2000563808 hasConcept C86803240 @default.
- W2000563808 hasConceptScore W2000563808C121608353 @default.
- W2000563808 hasConceptScore W2000563808C126322002 @default.
- W2000563808 hasConceptScore W2000563808C2777331542 @default.
- W2000563808 hasConceptScore W2000563808C2777982462 @default.
- W2000563808 hasConceptScore W2000563808C2780210213 @default.
- W2000563808 hasConceptScore W2000563808C2781182431 @default.